DiMauro, Kimberly A. http://orcid.org/0009-0009-1827-1937
Swetlik, Carol http://orcid.org/0000-0002-4411-8612
Cohen, Jeffrey A. http://orcid.org/0000-0001-9245-9772
Article History
Received: 20 December 2023
Revised: 2 April 2024
Accepted: 14 April 2024
First Online: 30 April 2024
Declarations
:
: Dr. Kimberly DiMauro has no conflicts to report. Dr. Carol Swetlik has no conflicts to report. Dr. Jeffrey Cohen received personal compensation for consulting for Astoria, Bristol-Myers Squibb, Convelo, EMD Serono, FiND Therapeutics, INMune, and Sandoz; and serving as an Editor of <i>Multiple Sclerosis Journal.</i>
: An ethics statement is not applicable because this article is based on published literature.